nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—kidney cancer—adrenal gland cancer	0.71	1	CtDrD
Temsirolimus—ABCB1—adrenal gland cancer	0.245	1	CbGaD
Temsirolimus—Sirolimus—ABCB1—adrenal gland cancer	0.000556	0.5	CrCbGaD
Temsirolimus—Tacrolimus—ABCB1—adrenal gland cancer	0.000556	0.5	CrCbGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000162	0.00372	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—PRKACA—adrenal gland cancer	0.000161	0.00371	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—PRKACA—adrenal gland cancer	0.00016	0.00369	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—BAD—adrenal gland cancer	0.000159	0.00366	CbGpPWpGaD
Temsirolimus—MTOR—Wnt Signaling Pathway Netpath—CTNNB1—adrenal gland cancer	0.000157	0.0036	CbGpPWpGaD
Temsirolimus—CYP3A7—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000155	0.00355	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—CDC42—adrenal gland cancer	0.000151	0.00347	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—PRKACA—adrenal gland cancer	0.000151	0.00347	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—PRKACA—adrenal gland cancer	0.000151	0.00347	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—PRKACA—adrenal gland cancer	0.00015	0.00344	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.00015	0.00344	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—PRKACA—adrenal gland cancer	0.000148	0.00341	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—PRKACA—adrenal gland cancer	0.000148	0.00339	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000145	0.00334	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—BAD—adrenal gland cancer	0.000143	0.0033	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—BAD—adrenal gland cancer	0.00014	0.00322	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—BAD—adrenal gland cancer	0.000139	0.00319	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—CDC42—adrenal gland cancer	0.000137	0.00316	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—SH3KBP1—adrenal gland cancer	0.000137	0.00314	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SH3KBP1—adrenal gland cancer	0.000136	0.00313	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—BAD—adrenal gland cancer	0.000136	0.00312	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—BAD—adrenal gland cancer	0.000136	0.00312	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—PRKACA—adrenal gland cancer	0.000134	0.00307	CbGpPWpGaD
Temsirolimus—MTOR—Insulin Signaling—IGF1R—adrenal gland cancer	0.000129	0.00297	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—ZNRF3—adrenal gland cancer	0.000128	0.00294	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CDC42—adrenal gland cancer	0.000127	0.00292	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CDC42—adrenal gland cancer	0.000126	0.00289	CbGpPWpGaD
Temsirolimus—CYP3A7—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.000125	0.00288	CbGpPWpGaD
Temsirolimus—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000125	0.00288	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—BRAF—adrenal gland cancer	0.000124	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—BRAF—adrenal gland cancer	0.000124	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—CDC42 signaling events—CTNNB1—adrenal gland cancer	0.000124	0.00284	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—RB1—adrenal gland cancer	0.000121	0.00279	CbGpPWpGaD
Temsirolimus—MTOR—LKB1 signaling events—TP53—adrenal gland cancer	0.000121	0.00279	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000121	0.00278	CbGpPWpGaD
Temsirolimus—MTOR—ErbB Signaling Pathway—EGFR—adrenal gland cancer	0.00012	0.00277	CbGpPWpGaD
Temsirolimus—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000119	0.00274	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000115	0.00263	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000112	0.00258	CbGpPWpGaD
Temsirolimus—CYP3A5—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000112	0.00257	CbGpPWpGaD
Temsirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—CTNNB1—adrenal gland cancer	0.000111	0.00255	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	0.00011	0.00253	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—BAD—adrenal gland cancer	0.000107	0.00246	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—CTNNB1—adrenal gland cancer	0.000107	0.00245	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—CDKN2A—adrenal gland cancer	0.000107	0.00245	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—BAD—adrenal gland cancer	0.000105	0.00242	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—PRKACA—adrenal gland cancer	0.000103	0.00236	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—BAD—adrenal gland cancer	0.000103	0.00236	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GNRHR—adrenal gland cancer	0.000102	0.00236	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000101	0.00233	CbGpPWpGaD
Temsirolimus—MTOR—ErbB Signaling Pathway—TP53—adrenal gland cancer	0.000101	0.00232	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—BAD—adrenal gland cancer	0.000101	0.00232	CbGpPWpGaD
Temsirolimus—MTOR—Regulation of Telomerase—EGFR—adrenal gland cancer	0.0001	0.0023	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	9.84e-05	0.00226	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—TERT—adrenal gland cancer	9.74e-05	0.00224	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—BAD—adrenal gland cancer	9.64e-05	0.00222	CbGpPWpGaD
Temsirolimus—FKBP1A—Spinal Cord Injury—TP53—adrenal gland cancer	9.62e-05	0.00221	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—BAD—adrenal gland cancer	9.59e-05	0.00221	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—BAD—adrenal gland cancer	9.55e-05	0.00219	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.53e-05	0.00219	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—BAD—adrenal gland cancer	9.5e-05	0.00218	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—BAD—adrenal gland cancer	9.36e-05	0.00215	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	9.24e-05	0.00212	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	9.08e-05	0.00209	CbGpPWpGaD
Temsirolimus—CYP3A5—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	9.05e-05	0.00208	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ZNRF3—adrenal gland cancer	8.96e-05	0.00206	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—BAD—adrenal gland cancer	8.94e-05	0.00205	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—BAD—adrenal gland cancer	8.94e-05	0.00205	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—BAD—adrenal gland cancer	8.94e-05	0.00205	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—BAD—adrenal gland cancer	8.86e-05	0.00204	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—CTNNB1—adrenal gland cancer	8.8e-05	0.00202	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—BAD—adrenal gland cancer	8.78e-05	0.00202	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—BAD—adrenal gland cancer	8.74e-05	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—BRAF—adrenal gland cancer	8.73e-05	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—BRAF—adrenal gland cancer	8.73e-05	0.00201	CbGpPWpGaD
Temsirolimus—MTOR—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	8.72e-05	0.002	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—TP53—adrenal gland cancer	8.31e-05	0.00191	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—CTNNB1—adrenal gland cancer	8.3e-05	0.00191	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—EGFR—adrenal gland cancer	8.3e-05	0.00191	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—SH3KBP1—adrenal gland cancer	8.29e-05	0.00191	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—BAD—adrenal gland cancer	8.27e-05	0.0019	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—BRAF—adrenal gland cancer	8.14e-05	0.00187	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—SPRY2—adrenal gland cancer	8.02e-05	0.00184	CbGpPWpGaD
Temsirolimus—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	7.94e-05	0.00183	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—BAD—adrenal gland cancer	7.92e-05	0.00182	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	7.79e-05	0.00179	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SH3KBP1—adrenal gland cancer	7.65e-05	0.00176	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—EGFR—adrenal gland cancer	7.48e-05	0.00172	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MEN1—adrenal gland cancer	7.35e-05	0.00169	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—EGFR—adrenal gland cancer	7.3e-05	0.00168	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—EGFR—adrenal gland cancer	7.24e-05	0.00166	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—BRAF—adrenal gland cancer	7.21e-05	0.00166	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ZNRF3—adrenal gland cancer	7.19e-05	0.00165	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—EGFR—adrenal gland cancer	7.07e-05	0.00163	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—EGFR—adrenal gland cancer	7.07e-05	0.00163	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	6.95e-05	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—CTNNB1—adrenal gland cancer	6.94e-05	0.00159	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	6.68e-05	0.00153	CbGpPWpGaD
Temsirolimus—CYP3A7—Biological oxidations—POMC—adrenal gland cancer	6.65e-05	0.00153	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	6.54e-05	0.0015	CbGpPWpGaD
Temsirolimus—CYP2D6—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	6.44e-05	0.00148	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GNRH1—adrenal gland cancer	6.14e-05	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—BAD—adrenal gland cancer	6.09e-05	0.0014	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SDHB—adrenal gland cancer	5.95e-05	0.00137	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—adrenal gland cancer	5.94e-05	0.00137	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PRKACA—adrenal gland cancer	5.87e-05	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—RB1—adrenal gland cancer	5.81e-05	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNRHR—adrenal gland cancer	5.76e-05	0.00133	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PRKACA—adrenal gland cancer	5.63e-05	0.00129	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—SPRY2—adrenal gland cancer	5.62e-05	0.00129	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PRKACA—adrenal gland cancer	5.61e-05	0.00129	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—EGFR—adrenal gland cancer	5.59e-05	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—BRAF—adrenal gland cancer	5.54e-05	0.00127	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TSHR—adrenal gland cancer	5.47e-05	0.00126	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.36e-05	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—EGFR—adrenal gland cancer	5.35e-05	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	5.29e-05	0.00122	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—EGFR—adrenal gland cancer	5.26e-05	0.00121	CbGpPWpGaD
Temsirolimus—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	5.19e-05	0.00119	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MEN1—adrenal gland cancer	5.15e-05	0.00118	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN2A—adrenal gland cancer	5.1e-05	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ZNRF3—adrenal gland cancer	5.04e-05	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—EGFR—adrenal gland cancer	5.03e-05	0.00116	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—EGFR—adrenal gland cancer	5e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—EGFR—adrenal gland cancer	5e-05	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—EGFR—adrenal gland cancer	4.98e-05	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDC42—adrenal gland cancer	4.98e-05	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—EGFR—adrenal gland cancer	4.95e-05	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—EGFR—adrenal gland cancer	4.88e-05	0.00112	CbGpPWpGaD
Temsirolimus—CYP3A5—Biological oxidations—POMC—adrenal gland cancer	4.81e-05	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDC42—adrenal gland cancer	4.78e-05	0.0011	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDC42—adrenal gland cancer	4.76e-05	0.00109	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—EGFR—adrenal gland cancer	4.66e-05	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—EGFR—adrenal gland cancer	4.66e-05	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—EGFR—adrenal gland cancer	4.66e-05	0.00107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—EGFR—adrenal gland cancer	4.62e-05	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—EGFR—adrenal gland cancer	4.58e-05	0.00105	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—EGFR—adrenal gland cancer	4.56e-05	0.00105	CbGpPWpGaD
Temsirolimus—MTOR—Disease—SPRY2—adrenal gland cancer	4.51e-05	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	4.44e-05	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—EGFR—adrenal gland cancer	4.31e-05	0.000991	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SDHB—adrenal gland cancer	4.3e-05	0.000989	CbGpPWpGaD
Temsirolimus—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	4.21e-05	0.000968	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MEN1—adrenal gland cancer	4.13e-05	0.00095	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—EGFR—adrenal gland cancer	4.13e-05	0.000949	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PRKACA—adrenal gland cancer	3.93e-05	0.000903	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—RRM1—adrenal gland cancer	3.83e-05	0.000881	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SDHD—adrenal gland cancer	3.83e-05	0.000881	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TERT—adrenal gland cancer	3.82e-05	0.000877	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	3.62e-05	0.000832	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—BAD—adrenal gland cancer	3.47e-05	0.000798	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNRH1—adrenal gland cancer	3.45e-05	0.000794	CbGpPWpGaD
Temsirolimus—CYP2D6—Biological oxidations—POMC—adrenal gland cancer	3.42e-05	0.000786	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PRKACA—adrenal gland cancer	3.42e-05	0.000785	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—BAD—adrenal gland cancer	3.33e-05	0.000767	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDC42—adrenal gland cancer	3.33e-05	0.000766	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—BAD—adrenal gland cancer	3.32e-05	0.000763	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SDHB—adrenal gland cancer	3.24e-05	0.000746	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF2—adrenal gland cancer	3.21e-05	0.000738	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GNAS—adrenal gland cancer	3.18e-05	0.000732	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—EGFR—adrenal gland cancer	3.17e-05	0.00073	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPRY2—adrenal gland cancer	3.16e-05	0.000726	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PRKACA—adrenal gland cancer	3.15e-05	0.000725	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IGF1R—adrenal gland cancer	3.1e-05	0.000714	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TSHR—adrenal gland cancer	3.08e-05	0.000708	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SDHB—adrenal gland cancer	3.06e-05	0.000703	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—BRAF—adrenal gland cancer	3.02e-05	0.000695	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDC42—adrenal gland cancer	2.9e-05	0.000666	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MEN1—adrenal gland cancer	2.89e-05	0.000665	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—MED12—adrenal gland cancer	2.86e-05	0.000657	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—TP53—adrenal gland cancer	2.84e-05	0.000653	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—RRM1—adrenal gland cancer	2.77e-05	0.000637	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SDHD—adrenal gland cancer	2.77e-05	0.000637	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDC42—adrenal gland cancer	2.68e-05	0.000615	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TERT—adrenal gland cancer	2.67e-05	0.000614	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	2.66e-05	0.000612	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTGS2—adrenal gland cancer	2.44e-05	0.000561	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—PRKACA—adrenal gland cancer	2.43e-05	0.000558	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	2.38e-05	0.000548	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—BAD—adrenal gland cancer	2.33e-05	0.000535	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CTNNB1—adrenal gland cancer	2.28e-05	0.000525	CbGpPWpGaD
Temsirolimus—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.24e-05	0.000514	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PRKACA—adrenal gland cancer	2.21e-05	0.000508	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CTNNB1—adrenal gland cancer	2.18e-05	0.000502	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TERT—adrenal gland cancer	2.15e-05	0.000493	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—POMC—adrenal gland cancer	2.14e-05	0.000493	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—BRAF—adrenal gland cancer	2.12e-05	0.000487	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—RRM1—adrenal gland cancer	2.09e-05	0.000481	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SDHD—adrenal gland cancer	2.09e-05	0.000481	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PRKACA—adrenal gland cancer	2.09e-05	0.000479	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—MED12—adrenal gland cancer	2.07e-05	0.000475	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BAD—adrenal gland cancer	2.02e-05	0.000465	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2e-05	0.00046	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—RRM1—adrenal gland cancer	1.97e-05	0.000453	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SDHD—adrenal gland cancer	1.97e-05	0.000453	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—GNAS—adrenal gland cancer	1.97e-05	0.000452	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	1.89e-05	0.000434	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDC42—adrenal gland cancer	1.87e-05	0.000431	CbGpPWpGaD
Temsirolimus—MTOR—Disease—BAD—adrenal gland cancer	1.87e-05	0.000429	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—adrenal gland cancer	1.81e-05	0.000416	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF2—adrenal gland cancer	1.81e-05	0.000415	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNAS—adrenal gland cancer	1.79e-05	0.000412	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IGF1R—adrenal gland cancer	1.75e-05	0.000401	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—adrenal gland cancer	1.74e-05	0.0004	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—adrenal gland cancer	1.73e-05	0.000398	CbGpPWpGaD
Temsirolimus—MTOR—Disease—BRAF—adrenal gland cancer	1.7e-05	0.000391	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GNAS—adrenal gland cancer	1.69e-05	0.000388	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—ABCB1—adrenal gland cancer	1.66e-05	0.000381	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	1.58e-05	0.000364	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—MED12—adrenal gland cancer	1.56e-05	0.000358	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CTNNB1—adrenal gland cancer	1.53e-05	0.000352	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PRKACA—adrenal gland cancer	1.51e-05	0.000346	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TERT—adrenal gland cancer	1.5e-05	0.000346	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—MED12—adrenal gland cancer	1.47e-05	0.000338	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—adrenal gland cancer	1.37e-05	0.000316	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CTNNB1—adrenal gland cancer	1.33e-05	0.000306	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BAD—adrenal gland cancer	1.31e-05	0.000301	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.29e-05	0.000296	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.29e-05	0.000296	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CTNNB1—adrenal gland cancer	1.23e-05	0.000282	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GNAS—adrenal gland cancer	1.22e-05	0.000281	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—adrenal gland cancer	1.21e-05	0.000279	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—POMC—adrenal gland cancer	1.21e-05	0.000277	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—ABCB1—adrenal gland cancer	1.2e-05	0.000276	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BRAF—adrenal gland cancer	1.19e-05	0.000274	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—POMC—adrenal gland cancer	1.14e-05	0.000262	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PRKACA—adrenal gland cancer	1.14e-05	0.000261	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PRKACA—adrenal gland cancer	1.07e-05	0.000246	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—adrenal gland cancer	1.05e-05	0.000242	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—adrenal gland cancer	1.02e-05	0.000234	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—adrenal gland cancer	9.73e-06	0.000224	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—MED12—adrenal gland cancer	9.6e-06	0.000221	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GNAS—adrenal gland cancer	9.22e-06	0.000212	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—adrenal gland cancer	9.08e-06	0.000209	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GNAS—adrenal gland cancer	8.69e-06	0.0002	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CTNNB1—adrenal gland cancer	8.6e-06	0.000198	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—ABCB1—adrenal gland cancer	8.52e-06	0.000196	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—POMC—adrenal gland cancer	8.22e-06	0.000189	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	7.01e-06	0.000161	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—adrenal gland cancer	6.82e-06	0.000157	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—adrenal gland cancer	6.56e-06	0.000151	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—POMC—adrenal gland cancer	6.21e-06	0.000143	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—POMC—adrenal gland cancer	5.85e-06	0.000134	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—adrenal gland cancer	5.72e-06	0.000132	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GNAS—adrenal gland cancer	5.68e-06	0.000131	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	5.57e-06	0.000128	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—adrenal gland cancer	4.95e-06	0.000114	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—adrenal gland cancer	4.66e-06	0.000107	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—POMC—adrenal gland cancer	3.82e-06	8.79e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.05e-06	7.01e-05	CbGpPWpGaD
